CHEK vs BCLI
Comparison between Check-Cap Ltd (CHEK, Company) and Brainstorm Cell Therapeutics Inc (BCLI, Company).
Both CHEK and BCLI are from the Healthcare sector.
5-Year PerformanceCHEK has outperformed BCLI, delivering a return of -27.2% compared to -56.8%
CHEK vs BCLI - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
CHEK vs BCLI - Historical Returns
Returns include dividend reinvestment.
CHEK vs BCLI - Annual Returns (2003 - 2026)
Returns include dividend reinvestment.
| Year | CHEK | BCLI |
|---|---|---|
| 2026 | N/A | +38.64% |
| 2025 | +39.39% | -74.16% |
| 2024 | -50.75% | -46.90% |
| 2023 | -14.75% | -83.65% |
| 2022 | -83.99% | -60.86% |
| 2021 | -53.47% | -11.89% |
| 2020 | -73.41% | +9.83% |
| 2019 | -24.23% | +23.70% |
| 2018 | -80.31% | -2.74% |
| 2017 | -63.60% | +53.13% |
| 2016 | +16.92% | -13.90% |
| 2015 | -68.91% | -61.87% |
| 2014 | N/A | +67.01% |
| 2013 | N/A | -25.00% |
| 2012 | N/A | -8.33% |
| 2011 | N/A | +5.00% |
| 2010 | N/A | -26.92% |
| 2009 | N/A | +224.98% |
| 2008 | N/A | -89.83% |
| 2007 | N/A | +132.15% |
| 2006 | N/A | -49.09% |
| 2005 | N/A | -77.50% |
| 2004 | N/A | +99.00% |
| 2003 | N/A | +212.22% |
CHEK vs BCLI Drawdown Comparison
The maximum drawdown for CHEK was -99.96%, occurring on Dec 19, 2024. This drawdown has not yet recovered.
The maximum drawdown for BCLI was -99.94%, occurring on Feb 17, 2026. This drawdown has not yet recovered.
The current CHEK drawdown is -99.89%. The current BCLI drawdown is -99.89%.
| Rank | CHEK | BCLI |
|---|---|---|
| #1 | -99.96% Mar 5, 2015 - Dec 19, 2024 | -99.94% Jan 7, 2005 - Feb 17, 2026 |
| #2 | N/A | -50.00% Oct 21, 2003 - Nov 4, 2004 |
| #3 | N/A | -9.00% Dec 15, 2004 - Jan 6, 2005 |
| #4 | N/A | -7.27% Oct 3, 2003 - Oct 9, 2003 |
| #5 | N/A | -4.64% Nov 26, 2004 - Dec 13, 2004 |
| #6 | N/A | -2.29% Sep 22, 2003 - Oct 3, 2003 |
Correlation
Correlation between CHEK and BCLI is 0.03 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks